Biomerica achieves IVDR certification in European union

Biomerica (BMRA) announces that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the European Union’s new In Vitro Diagnostic Medical Devices Regulation. This certification marks a significant milestone for Biomerica, underscoring the company’s commitment to expanding its products in international markets. The newly approved food intolerance products are designed to address the growing need for non-invasive and personalized therapies to manage Crohn’s Disease and Ulcerative Colitis, conditions affecting millions worldwide.